Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
967.6500 -0.80 (-0.08%)
NSE Jul 15, 2025 15:31 PM
Volume: 553.3K
 

logo
Zydus Lifesciences Ltd.
15 Mar 2019, 12:00AM
967.65
-0.08%
Geojit BNP Paribas
Robust US sales; high debt remains a concern Cadila Healthcare (Cadila) is India's leading vertically integrated pharmaceutical company. With its presence across the value chain, it manufactures finished dosage forms, active pharmaceutical...
Zydus Lifesciences L.. has an average target of 988.60 from 5 brokers.
More from Zydus Lifescience…
All earning calls
Investor presentations from Zydus Lifescience…
All investor presentations